Significance of High P53 Protein Expression in Astrocytomas
Keywords:
anaplastic astrocytoma, diffuse astrocytoma, p53 protein
Abstract
Research objective: Analysis and evaluation of immunohistochemical positivity of p53 tumor protein in astrocytomas.
References
1. Trunin Yu.Yu "Stereotaxicheskaya obluchenie v kompleksnom lecheniii patientsov s piloidnymi astrocytomami" 2021g.
2. Kazarova M.V. "The role of prognostic factors in the selection of options for post-operative therapy in combined and complex treatment of primary anaplastic glioma of the brain" 2016.
3. O.M. Vorobeva "The phenomenon of pseudotumorous cross-immunohistochemical reactivity of glial in progressive multifocal leukoencephalopathy" 2022.
4. Rostovtsev D.M. "Malignant supratentorial astrocytic tumors: organization of medical assistants, new technologies and results of treatment" 2016g.
5. Lisyanyi N.I "Disruption of apoptotic processes in glioma brain" 2004.
6. Kolotov K.A. "Immunogistokhimicheskie osobennosti glialnyx tumor of the brain" 2012 g.
7. P.V. Nikitin "Molecular and histological heterogeneity of glioblastoma" 2020.
8. Louis D.N., Ohgaki H., Wiesler O.D., Cavenee W.K., et al. al. WHO Classification of Tumors of the Central Nervous System. – IARC: Lyon, 2007.
9. Matsko, D.E. Classification of central nervous system tumors WHO (2016) / D.E. Matsko, M.V. Matsko // Rossiyskiy neurokhirurgicheskiy zurnal im. Professor AL Polenova. - 2016. - T. 8. – no. 4. – S. 5-11.
10. Milyukov, S.M. Diagnosis and treatment of primary infiltrative glioma with low level of malignancy / S.M. Milyukov // Vestnik Rossiyskogo nauchnogo tsentra rentgenoradiologii Minzdrava Rossii. - 2016. - T. 16. – no. 2.
11. Matsko D.E., Korshunov A.G. Atlas of tumors of the central nervous system: (Histological structure). SPb.: SPb. RNAi im. Polenova.
12. Paltsev M.A., Frank G.A., Malkov P.G. Standartnye tekhnologicheskie protsedury pri morfologicheskom issledovanii biopsiynogo i operatsionnogo materiala. Archive pathology. 2011g.
2. Kazarova M.V. "The role of prognostic factors in the selection of options for post-operative therapy in combined and complex treatment of primary anaplastic glioma of the brain" 2016.
3. O.M. Vorobeva "The phenomenon of pseudotumorous cross-immunohistochemical reactivity of glial in progressive multifocal leukoencephalopathy" 2022.
4. Rostovtsev D.M. "Malignant supratentorial astrocytic tumors: organization of medical assistants, new technologies and results of treatment" 2016g.
5. Lisyanyi N.I "Disruption of apoptotic processes in glioma brain" 2004.
6. Kolotov K.A. "Immunogistokhimicheskie osobennosti glialnyx tumor of the brain" 2012 g.
7. P.V. Nikitin "Molecular and histological heterogeneity of glioblastoma" 2020.
8. Louis D.N., Ohgaki H., Wiesler O.D., Cavenee W.K., et al. al. WHO Classification of Tumors of the Central Nervous System. – IARC: Lyon, 2007.
9. Matsko, D.E. Classification of central nervous system tumors WHO (2016) / D.E. Matsko, M.V. Matsko // Rossiyskiy neurokhirurgicheskiy zurnal im. Professor AL Polenova. - 2016. - T. 8. – no. 4. – S. 5-11.
10. Milyukov, S.M. Diagnosis and treatment of primary infiltrative glioma with low level of malignancy / S.M. Milyukov // Vestnik Rossiyskogo nauchnogo tsentra rentgenoradiologii Minzdrava Rossii. - 2016. - T. 16. – no. 2.
11. Matsko D.E., Korshunov A.G. Atlas of tumors of the central nervous system: (Histological structure). SPb.: SPb. RNAi im. Polenova.
12. Paltsev M.A., Frank G.A., Malkov P.G. Standartnye tekhnologicheskie protsedury pri morfologicheskom issledovanii biopsiynogo i operatsionnogo materiala. Archive pathology. 2011g.
Published
2023-10-26
How to Cite
H. J. Beknazarov, X. A. Rasulov., & D. A. Nishanov. (2023). Significance of High P53 Protein Expression in Astrocytomas. Central Asian Journal of Medical and Natural Science, 4(5), 858-859. https://doi.org/10.17605/cajmns.v4i5.1932
Section
Articles
